George Shunda
Corneal and Contact Management · Newport Beach, CANPI 1346434909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,491, 3.4 times the $437 reported in 2019.
Across 162 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe US, Inc.$448
- Alcon$392
- Mallinckrodt Hospital Products Inc.$371
- Tarsus Pharmaceuticals, Inc.$351
- AbbVie$214
- Rxsight Inc$202
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,642100%
- Entertainment$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe US, Inc. | 19 | $448 |
| Alcon | 13 | $392 |
| Mallinckrodt Hospital Products Inc. | 20 | $371 |
| Tarsus Pharmaceuticals, Inc. | 19 | $351 |
| AbbVie(2 entities) | 9 | $214 |
| Rxsight Inc | 6 | $202 |
| Bausch & Lomb Americas Inc. | 8 | $180 |
| ANI Pharmaceuticals, Inc. | 10 | $176 |
| Novartis | 8 | $171 |
| Oyster Point Pharma, Inc. | 6 | $158 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $155 |
| Glaukos Corporation | 4 | $150 |
| Kala Pharmaceuticals, Inc. | 3 | $130 |
| Shire North American Group Inc | 8 | $128 |
| Sun Pharmaceutical Industries Inc. | 5 | $94 |
| Harrow Eye, LLC | 3 | $84 |
| Optos, Inc. | 2 | $41 |
| Thea Pharma Inc. | 2 | $39 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $37 |
| Carl Zeiss Meditec USA, Inc. | 1 | $37 |
| Alcon Research LLC | 1 | $33 |
| Ocular Therapeutix, Inc. | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $17 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Aerie Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,661 in reported general payments places this provider in the 75th percentile of 140 corneal and contact management providers in California.
See all corneal and contact management providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other corneal and contact management in Newport Beach
- Milton HomAzusa$762K
- Kambiz SilaniBeverly Hills$123K
- Gloria ChiuLos Angeles$80K
- John GellesSunnyvale$37K
- Nathan SchrammCosta Mesa$34K
- Jasdeep SoniBakersfield$26K
- Arti ShahCerritos$20K
- Gregory TomSan Ramon$16K
- Jay MashoufSan Diego$14K
- Ruth TangIrvine$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.